The US Food and Drug Administration (FDA) has approved a medicine that would reduce the risk of acquiring HIV in adult ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

General Mills announced plans to eliminate all artificial colors from its U.S. foods by 2027, with the removal of synthetic dyes from cereals and foods served in schools set to take effect by the ...

General Mills says “certified colors" will be removed from all U.S. cereals and K-12 school foods by summer of 2026.

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

CSL Behring’s Andembry is now approved as a subcutaneous, self-injection for hereditary angioedema (HAE) patients ages 12 and older and will be available by the end of June 2025.

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have ...